Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Endocrinol Diabetes Nutr (Engl Ed) ; 70(1): 29-38, 2023 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-36764745

RESUMEN

AIM: To assess the degree of compliance with the European ESC/EAS 2016 and 2019 dyslipidaemia guidelines in patients with type 2 diabetes mellitus (T2DM). METHODS: Multicentre retrospective cross-sectional study, conducted in 380 adults with T2DM and dyslipidaemia in 7 Spanish health areas. INCLUSION CRITERIA: minimum follow-up of one year in Endocrinology Units, at least one visit in 2020 and a lipid profile measurement in the last 3 months. EXCLUSION CRITERIA: familial hypercholesterolaemia, recent hospitalisation, active oncological pathology and dialysis. RESULTS: According to the 2016 and 2019 guidelines the majority of patients were classified as being at very high cardiovascular risk (86.8% vs. 72.1%, respectively). LDL-c compliance was adequate in 62.1% of patients according to the 2016 guidelines and 39.7% according to the 2019 guidelines (p<0.001). Clinical conditions such as history of cardiovascular disease and therapy-related aspects (use of statins, especially high-potency statins, combination therapies and good adherence) were significantly associated with greater achievement of lipid targets. CONCLUSION: There is a discrepancy between dyslipidaemia guideline recommendations and the reality of lipid control in patients with T2DM, despite most of these patients being at very high cardiovascular risk. Strategies to optimise lipid-lowering treatments need to be implemented.


Asunto(s)
Diabetes Mellitus Tipo 2 , Dislipidemias , Inhibidores de Hidroximetilglutaril-CoA Reductasas , Adulto , Humanos , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Diabetes Mellitus Tipo 2/complicaciones , Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico , España , Estudios Transversales , Estudios Retrospectivos , LDL-Colesterol , Dislipidemias/complicaciones
2.
Endocrinol Nutr ; 55(3): 149-51, 2008 Mar.
Artículo en Inglés, Español | MEDLINE | ID: mdl-22967883

RESUMEN

Adrenal incidentalomas are adrenal masses detected during radiologic examination performed for an indication otherthan evaluation of adrenal disease. Diagnosis of these masses has increased due to the widespread use of ultrasonography, computed tomography (CT) and magnetic resonance imaging. We report the case of a 69-year-old woman with a left adrenal incidentaloma simulating a non-functioning adenoma and right adrenal atrophy. The results of contrast-enhanced CT and subsequent histopathological study confirmed the diagnosis of adrenal tuberculosis. Hormonal study revealed partial adrenal insufficiency as a result of bilateral involvement of the adrenal tuberculosis.

3.
Arq Bras Endocrinol Metabol ; 52(6): 1066-70, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18820819

RESUMEN

Ectopic ACTH production occurs in about 10% of all cases of Cushing's syndrome, and about 25% of cases of ACTH-dependent Cushing's syndrome. Diverse tumor types are able to produce ACTH ectopically, including small cell lung carcinoma. Ectopic ACTH secretion by malignant neoplasm has been reported to have earlier and more aggressive metabolic effects. We report a 59-year-old male patient with severe hypertension, metabolic alkalosis and hypokalemia as the first clinical manifestations of an ACTH-secreting small cell lung carcinoma, although the typical phenotypic features of Cushing's syndrome were not present. Ectopic Cushing's syndrome should always be ruled out in patients with severe hypertension and hypokalemia.


Asunto(s)
Síndrome de ACTH Ectópico/diagnóstico , Síndrome de Cushing/diagnóstico , Hipertensión/diagnóstico , Hipopotasemia/diagnóstico , Neoplasias Pulmonares/metabolismo , Carcinoma Pulmonar de Células Pequeñas/metabolismo , Alcalosis/diagnóstico , Resultado Fatal , Humanos , Hidrocortisona/sangre , Hidrocortisona/metabolismo , Hidrocortisona/orina , Hipertensión/metabolismo , Hipopotasemia/tratamiento farmacológico , Masculino , Persona de Mediana Edad
4.
Arq. bras. endocrinol. metab ; 52(6): 1066-1070, ago. 2008. graf, tab
Artículo en Inglés | LILACS | ID: lil-492939

RESUMEN

Ectopic ACTH production occurs in about 10 percent of all cases of Cushing's syndrome, and about 25 percent of cases of ACTH-dependent Cushing's syndrome. Diverse tumor types are able to produce ACTH ectopically, including small cell lung carcinoma. Ectopic ACTH secretion by malignant neoplasm has been reported to have earlier and more aggressive metabolic effects. We report a 59-year-old male patient with severe hypertension, metabolic alkalosis and hypokalemia as the first clinical manifestations of an ACTH-secreting small cell lung carcinoma, although the typical phenotypic features of Cushing's syndrome were not present. Ectopic Cushing's syndrome should always be ruled out in patients with severe hypertension and hypokalemia.


A produção de ACTH ectópico ocorre em aproximadamente 10 por cento dos casos de síndrome de Cushing, e em aproximadamente 25 por cento dos casos de síndrome de Cushing dependentes de ACTH. Diversos tipos de tumores são capazes de produzir ACTH ectopicamente, incluindo carcinoma pulmonar de células pequenas. Relatórios indicam que a secreção de ACTH ectópico por neoplasma maligno causa efeitos metabólicos prematuros e mais agressivos. Apresentamos um paciente, 59 anos, com hipertensão grave, alcalose metabólica e hipocalemia, tendo estas como as primeiras manifestações clínicas de um carcinoma pulmonar de células pequenas com secreção de ACTH, embora as características fenótipas típicas da síndrome de Cushing não estavam presentes. A síndrome de Cushing ectópica deveria ser excluída sempre em pacientes com hipertensão grave e hipocalemia.


Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Síndrome de ACTH Ectópico/diagnóstico , Síndrome de Cushing/diagnóstico , Hipertensión/diagnóstico , Hipopotasemia/diagnóstico , Neoplasias Pulmonares , Carcinoma Pulmonar de Células Pequeñas , Alcalosis/diagnóstico , Resultado Fatal , Hidrocortisona/sangre , Hidrocortisona/metabolismo , Hidrocortisona/orina , Hipertensión/metabolismo , Hipopotasemia/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA